In cancer, CXCL12 regulates homing via the establishment of a hypoxia-dependent gradient that drives BMDCs to the CSC niche in the primary tumor or by building up the metastatic niche where needed, to ensure CSC growth and the generation of new vasculature [189]. Here, CXCL12 is linked to cancer.